Altered balance between matrix gelatinases (MMP‐2 and MMP‐9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP‐9 in myosin‐heavy chain degradation
Open Access
- 1 December 1999
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 1 (4) , 337-352
- https://doi.org/10.1016/s1388-9842(99)00048-3
Abstract
Background: End‐stage of human dilated cardiomyopathy (DCM) is characterized by myocyte loss and fibrosis, and associated with ventricular dilatation and reduced cardiac function. Matrix metalloproteinases (MMPs) and their natural tissue inhibitors (TIMPs) have been involved in the myocardial remodeling. Aims: To evaluate the potential role of matrix gelatinases (MMP‐2 and MMP‐9) in DCM, the balance between gelatinases and TIMPs and the gelatinase localization were investigated in left free wall ventricles from six normal donors and six patients with DCM at the transplantation time. Methods: TIMP‐(1, 2, 3 and 4) mRNAs were analyzed by quantitative reverse transcription‐polymerase chain reaction (RT‐PCR). TIMP‐1 and ‐2 protein content was assessed by ELISA. MMP‐2 and MMP‐9 expression were examined by zymography and immunological techniques. Results: All TIMPs were down‐regulated in DCM hearts, especially TIMP‐1 (reduced by 80%). Gel zymography revealed similar activity of MMP‐2 and MMP‐9 in both tissues. By in situ zymography and immunohistochemistry, active and immunoreactive gelatinases were pericardiomyocyte in control hearts and intracardiomyocyte in DCM hearts. Intracellular MMPs were associated with sarcomeric structure in DCM. To estimate a putative role of these gelatinases, several sarcomeric contractile proteins were digested in vitro by purified active MMP‐9. Only myosin‐heavy chain was cleaved in vitro giving 180‐, 120‐, 80‐ and 20‐kDa proteolytic fragments. In vivo, two major myosin‐heavy chain proteolytic fragments (80 and 20 kDa) were detected by specific monoclonal antibody against myosin‐heavy chain in DCM left ventricular homogenates, only. Conclusions: Taken together, these data highly suggest that MMP‐2 and MMP‐9 may be involved in the disorganization of the contractile apparatus in DCM hearts.Keywords
This publication has 51 references indexed in Scilit:
- Differential gene expression of extracellular matrix components in dilated cardiomyopathyJournal of Cellular Biochemistry, 1996
- Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: A quantitative assessmentJournal of the American College of Cardiology, 1995
- Human progelatinase A can be activated by matrilysinFEBS Letters, 1994
- Abnormalities of contractile structures in viable myocytes of the failing heartInternational Journal of Cardiology, 1994
- Activation of the 92 kDa type IV collagenase by tissue kallikreinJournal of Cellular Physiology, 1993
- Enhanced deposition of predominantly type I collagen in myocardial diseaseJournal of Molecular and Cellular Cardiology, 1990
- Pathologic anatomy of the dilated cardiomyopathiesThe American Journal of Cardiology, 1989
- Morphological Approach to the Mechanism of Heart FailureCardiology, 1988
- Idiopathic dilated Cardiomyopathy: Analysis of 152 necropsy patientsThe American Journal of Cardiology, 1987
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980